|
Volumn 8, Issue 4, 2010, Pages 232-233
|
Pazopanib in renal cell carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOKINE;
PAZOPANIB;
PLACEBO;
SUNITINIB;
ANTINEOPLASTIC AGENT;
PYRIMIDINE DERIVATIVE;
SULFONAMIDE;
ADVANCED CANCER;
ANOREXIA;
ANTIANGIOGENIC ACTIVITY;
ARTICLE;
DIARRHEA;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TOLERABILITY;
HAIR COLOR;
HUMAN;
HYPERTENSION;
KIDNEY CARCINOMA;
NAUSEA;
OVERALL SURVIVAL;
SIDE EFFECT;
TREATMENT RESPONSE;
VOMITING;
KIDNEY TUMOR;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
HUMANS;
KIDNEY NEOPLASMS;
PYRIMIDINES;
SULFONAMIDES;
|
EID: 77954060790
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (4)
|